A circulating miRNA marker related to auxiliary diagnosis of endometrial cancer and its application

An endometrial cancer, auxiliary diagnosis technology, applied in the fields of genetic engineering and oncology, can solve the problem of inconsistent research results, and achieve the effect of high sensitivity and specificity, minimally invasive and easy to obtain

Active Publication Date: 2022-02-11
朱伟
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to differences in research methods and included populations, the results of the studies were not completely consistent.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A circulating miRNA marker related to auxiliary diagnosis of endometrial cancer and its application
  • A circulating miRNA marker related to auxiliary diagnosis of endometrial cancer and its application
  • A circulating miRNA marker related to auxiliary diagnosis of endometrial cancer and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0040] The inventor collected a large number of venous plasma and serum samples from the First Affiliated Hospital of Nanjing Medical University and Nanjing Maternal and Child Health Hospital from 2015 to 2016. 181 cases of endometrial cancer and 197 samples of normal controls were selected as the experimental samples for the initial screening of Exiqon miRNA qPCR panel chip and subsequent series of qRT-PCR verification. At the same time, 24 cases of endometrial cancer tissues and 24 cases of paracancerous tissues were retained. The selected patients' plasma and serum samples were all from newly diagnosed patients who had not undergone surgery, radiotherapy and chemotherapy intervention and were pathologically confirmed as endometrial cancer. The demographic data and clinical data of these samples were collected systematically.

[0041] Refer to the flowchart ( figure 1 with figure 2 ), randomly selected 20 samples of endometrial cancer and 10 samples of normal controls fr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a circulating miRNA marker related to the auxiliary diagnosis of endometrial cancer and its application. The marker is a plasma marker miR-142-3p, miR-146a-5p and miR-151a-5p and a serum marker One or more of miR-143-3p, miR-195-5p, miR-20b-5p, miR-204-5p, miR-423-3p and miR-484. As a new type of biomarker, circulating miRNA has the characteristics of good stability, minimally invasive and easy access, high sensitivity and specificity. The development and utilization of such molecular markers will provide a new direction for the diagnosis and further treatment of various diseases including tumors. This study will be more targeted to obtain circulating miRNA markers with clinical diagnostic potential in endometrial cancer. The study confirmed the reliability and reproducibility of this group of miRNAs as non-invasive markers for the diagnosis of endometrial cancer.

Description

technical field [0001] The invention belongs to the fields of genetic engineering and oncology, and relates to a circulating miRNA marker related to the auxiliary diagnosis of endometrial cancer and its application. Background technique [0002] Endometrial cancer (EC) is one of the most common female malignancies in the world. According to Cancer Statistics in 2018, endometrial cancer is the sixth leading cause of death in women. Although more than 70% of patients are diagnosed at an early stage, most patients still die due to many factors, including late surgical stage, distant metastasis, treatment resistance and recurrence, and the 5-year survival rate is less than 40%. Moreover, pelvic examination, transvaginal B-ultrasound and tumor markers, such as carbohydrate antigen 125 (CA125), have been widely used clinically, but they are still not enough to completely detect the disease early and reduce the mortality rate of endometrial cancer. With the development of biotech...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/6886C12N15/11
CPCC12Q1/6886C12Q2600/158C12Q2600/178
Inventor 朱伟陈彦贾雪梅殷茵周鑫张获单霞夏添松邹璇
Owner 朱伟
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products